Maples Group Advises Hansoh Pharmaceutical on Vienna MTF Listing of Convertible Bonds
- Published
- in Deals
Maples and Calder, the Maples Group’s law firm, is pleased to announce it has advised Hansoh Pharmaceutical Group Company Limited (“Hansoh”) on its issuance of HK$4,680 million zero-coupon convertible bonds due 2033 (the “Bonds”) and the listing of the Bonds on the Vienna MTF (Multilateral Trading Facility) operated by the Vienna Stock Exchange. The listing was completed on 4 February 2026.
Hansoh is a leading pharmaceutical company engaged in the research, development, production and sale of a broad portfolio of pharmaceutical products.
A team based in the firm’s Hong Kong office acted as Cayman Islands counsel to Hansoh. The team was led by Matt Roberts, Partner and Head of Corporate, Asia, with assistance from Legal Managers, Kelvan Cheung and Clare Tsang.
Cleary Gottlieb Steen & Hamilton (Hong Kong) acted as English and Hong Kong legal counsel to Hansoh. Linklaters acted as English and Hong Kong legal counsel to the managers, Citigroup Global Markets Limited and Morgan Stanley Asia Limited.
